Upcoming FDA Guidance Will Offer New Thinking On Drug-Eluting Stents
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to issue a guidance document on drug-eluting stents in the next several months to communicate new premarket and postmarket recommendations for the heavily scrutinized products